Literature DB >> 19475051

Ultrahigh resolution Fourier domain optical coherence tomography.

R Leitgeb, W Drexler, A Unterhuber, B Hermann, T Bajraszewski, T Le, A Stingl, A Fercher.   

Abstract

We present, for the first time, in vivo ultrahigh resolution (~2.5 microm in tissue), high speed (10000 A-scans/second equivalent acquisition rate sustained over 160 A-scans) retinal imaging obtained with Fourier domain (FD) OCT employing a commercially available, compact (500x260mm), broad bandwidth (120 nm at full-width-at-half-maximum centered at 800 nm) Titanium:sapphire laser (Femtosource Integral OCT, Femtolasers Produktions GmbH). Resolution and sampling requirements, dispersion compensation as well as dynamic range for ultrahigh resolution FD OCT are carefully analyzed. In vivo OCT sensitivity performance achieved by ultrahigh resolution FD OCT was similar to that of ultrahigh resolution time domain OCT, although employing only 2-3 times less optical power (~300 microW). Visualization of intra-retinal layers, especially the inner and outer segment of the photoreceptor layer, obtained by FDOCT was comparable to that, accomplished by ultrahigh resolution time domain OCT, despite an at least 40 times higher data acquisition speed of FD OCT.

Entities:  

Year:  2004        PMID: 19475051     DOI: 10.1364/opex.12.002156

Source DB:  PubMed          Journal:  Opt Express        ISSN: 1094-4087            Impact factor:   3.894


  71 in total

Review 1.  [Methodological advancements. Ultrahigh-resolution OCT].

Authors:  W Drexler
Journal:  Ophthalmologe       Date:  2004-08       Impact factor: 1.059

Review 2.  Fiber optic in vivo imaging in the mammalian nervous system.

Authors:  Amit D Mehta; Juergen C Jung; Benjamin A Flusberg; Mark J Schnitzer
Journal:  Curr Opin Neurobiol       Date:  2004-10       Impact factor: 6.627

3.  Broadband superluminescent diode-based ultrahigh resolution optical coherence tomography for ophthalmic imaging.

Authors:  Dexi Zhu; Meixiao Shen; Hong Jiang; Ming Li; Michael R Wang; Yuhong Wang; Lili Ge; Jia Qu; Jianhua Wang
Journal:  J Biomed Opt       Date:  2011-12       Impact factor: 3.170

4.  Quantitative analysis of the intraretinal layers and optic nerve head using ultra-high resolution optical coherence tomography.

Authors:  Yuhong Wang; Hong Jiang; Meixiao Shen; Byron L Lam; Delia Cabrera DeBuc; Yufeng Ye; Ming Li; Aizhu Tao; Yilei Shao; Jianhua Wang
Journal:  J Biomed Opt       Date:  2012-06       Impact factor: 3.170

5.  Master slave en-face OCT/SLO.

Authors:  Adrian Bradu; Konstantin Kapinchev; Frederick Barnes; Adrian Podoleanu
Journal:  Biomed Opt Express       Date:  2015-08-27       Impact factor: 3.732

6.  Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography.

Authors:  Maciej Wojtkowski; Vivek Srinivasan; James G Fujimoto; Tony Ko; Joel S Schuman; Andrzej Kowalczyk; Jay S Duker
Journal:  Ophthalmology       Date:  2005-10       Impact factor: 12.079

7.  Rapid, depth-resolved light scattering measurements using Fourier domain, angle-resolved low coherence interferometry.

Authors:  John W Pyhtila; Adam Wax
Journal:  Opt Express       Date:  2004-12-13       Impact factor: 3.894

8.  High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography.

Authors:  Vivek J Srinivasan; Maciej Wojtkowski; Andre J Witkin; Jay S Duker; Tony H Ko; Mariana Carvalho; Joel S Schuman; Andrzej Kowalczyk; James G Fujimoto
Journal:  Ophthalmology       Date:  2006-11       Impact factor: 12.079

9.  Retinal imaging using commercial broadband optical coherence tomography.

Authors:  Hitesh Tanna; Adam M Dubis; Nazia Ayub; Diane M Tait; Jungtae Rha; Kimberly E Stepien; Joseph Carroll
Journal:  Br J Ophthalmol       Date:  2009-09-21       Impact factor: 4.638

10.  Polarization maintaining fiber based ultra-high resolution spectral domain polarization sensitive optical coherence tomography.

Authors:  Erich Götzinger; Bernhard Baumann; Michael Pircher; Christoph K Hitzenberger
Journal:  Opt Express       Date:  2009-12-07       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.